The Role of Azacitidine in the Treatment of Elderly Patients with Acute Myeloid Leukemia: Results of a Retrospective Multicenter Study.


Creative Commons License

Tombak A., Uçar M. A., Akdeniz A., Tiftik E. N., Gören Şahin D., Akay O. M., ...More

Turkish journal of haematology : official journal of Turkish Society of Haematology, vol.33, pp.273-280, 2016 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 33
  • Publication Date: 2016
  • Doi Number: 10.4274/tjh.2015.0203
  • Journal Name: Turkish journal of haematology : official journal of Turkish Society of Haematology
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.273-280
  • Keywords: Azacitidine, Acute myeloid leukemia, Elderly, Bone marrow blasts, Prognostic factors, Overall survival, CONVENTIONAL CARE REGIMENS, INTERNATIONAL WORKING GROUP, ACUTE MYELOGENOUS LEUKEMIA, NEWLY-DIAGNOSED AML, OLDER PATIENTS, INTENSIVE CHEMOTHERAPY, MYELODYSPLASTIC SYNDROME, RESPONSE CRITERIA, AGE, CYTARABINE
  • Akdeniz University Affiliated: Yes

Abstract

Objective: In this study, we aimed to investigate the efficacy and safety of azacitidine (AZA) in elderly patients with acute myeloid leukemia (AML), including patients with >30% bone marrow (BM) blasts.